Publications by authors named "David Rubenstein"

Claim this Profile
C
Cocaine affects astrocyte iNOS expression.
Wei Yin, Marina Fandaros, Yanzuo Liu, Ruohan Lei, George Pittas, David A Rubenstein

Brain Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials.
Linda Stein Gold, James Del Rosso, Benjamin D Ehst, Matthew J Zirwas, Lawrence J Green, David S Rubenstein

J Dermatolog Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitis.
Robert Bissonnette, Linda Stein Gold, Leon Kircik, Eric L Simpson, Lawrence F Eichenfield, David S Rubenstein

J Am Acad Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapinarof Cream for Adults and Children with Atopic Dermatitis-Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials.
Andrew F Alexis, Leon Kircik, Raj Chovatiya, Zakiya P Rice, Weily Soong, David S Rubenstein

Dermatol Ther (Heidelb)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation.
Carolina M Polonio, Kimberly A McHale, David H Sherr, David Rubenstein, Francisco J Quintana

Nat Rev Drug Discov· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Patient-Specific Mesoscopic Fluid-Structure Interaction Model of the Coronary Artery.
Elisabeth Steadman, Daphne Meza, David A Rubenstein, Wei Yin

Int J Numer Method Biomed Eng· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis.
Eric L Simpson, Jonathan I Silverberg, Robert Bissonnette, Linda Stein Gold, April Armstrong, David S Rubenstein

J Drugs Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis.
Amy S Paller, Adelaide A Hebert, Mercedes E Gonzalez, Victoria Butners, Nancy Fitzgerald, David S Rubenstein

Am J Clin Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives and Experiences of Patients with AKI: A Systematic Review.
Patrizia Natale, Rebecca Wu, Anastasia Hughes, Amanda Sluiter, David Ari Rubenstein

Clin J Am Soc Nephrol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children.
Eric L Simpson, Adelaide A Hebert, John Browning, Rocco T Serrao, Howard Sofen, David S Rubenstein

Dermatol Ther (Heidelb)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials.
Jonathan I Silverberg, Lawrence F Eichenfield, Adelaide A Hebert, Eric L Simpson, Linda Stein Gold, David S Rubenstein

J Am Acad Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review.
Jonathan I Silverberg, Mark Boguniewicz, Francisco J Quintana, Rachael A Clark, Lara Gross, David S Rubenstein

J Allergy Clin Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on Incorporating a Large Language Model into a Cellular and Molecular Bioengineering Graduate Course.
David A Rubenstein, Carsi Kim

Cell Mol Bioeng· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic Dermatitis.
Lawrence F Eichenfield, Jonathan I Silverberg, Adelaide A Hebert, Raj Chovatiya, Philip M Brown, David S Rubenstein

J Drugs Dermatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet and endothelial cell responses under concurrent shear stress and tensile strain.
Elisabeth Steadman, Danielle Steadman, David A Rubenstein, Wei Yin

Microvasc Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis.
Leon Kircik, Matthew Zirwas, Shawn G Kwatra, G Michael Lewitt, Holly Glover, David S Rubenstein

Dermatol Ther (Heidelb)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to Secondhand Smoke Extract Increases Cisplatin Resistance in Head and Neck Cancer Cells.
Balaji Sadhasivam, Jimmy Manyanga, Vengatesh Ganapathy, Pawan Acharya, Célia Bouharati, David A Rubenstein

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials.
Seemal R Desai, Linda Stein Gold, Michael C Cameron, Alexandra Golant, G Michael Lewitt, David S Rubenstein

Dermatol Ther (Heidelb)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement component C1q initiates extrinsic coagulation via the receptor for the globular head of C1q in adventitial fibroblasts and vascular smooth muscle cells.
Christopher T Freda, Wei Yin, Berhane Ghebrehiwet, David A Rubenstein

Immun Inflamm Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Milestones 2.0: An advancement in competency-based assessment for dermatology.
Kiran Motaparthi, Laura Edgar, William D Aughenbaugh, Anna L Bruckner, Alexa Leone, David Rubenstein

Clin Dermatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial.
Bruce Strober, Linda Stein Gold, Robert Bissonnette, April W Armstrong, Leon Kircik, David S Rubenstein

J Am Acad Dermatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermal Safety of Tapinarof Cream 1%: Results From 4 Phase 1 Trials.
John Jett, Michael McLaughlin, Timothy Wilson, Matthew Somerville, Wayne DellaMaestra, David Rubenstein

J Drugs Dermatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of 3D Printed Electrospun Scaffolds for the Fabrication of Porous Scaffolds for Vascular Applications.
Jahnvi Bansal, Katelyn Neuman, Vaughn K Greene, David A Rubenstein

3D Print Addit Manuf· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arthroscopic Suprapectoral Biceps Tenodesis: The Best of Both Worlds.
Tyler Pratte, Tyler Smith, Alfonso Arevalo, Joseph Wazen, David Rubenstein

Arthrosc Tech· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow.
Wei Yin, Andrew Dimatteo, Andrew Kumpfbeck, Stephen Leung, Marina Fandaros, David A Rubenstein

Thromb J· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis